CN110201100A - 一种防治三高症、动脉硬化及肥胖症的药食同源组方 - Google Patents

一种防治三高症、动脉硬化及肥胖症的药食同源组方 Download PDF

Info

Publication number
CN110201100A
CN110201100A CN201910558038.3A CN201910558038A CN110201100A CN 110201100 A CN110201100 A CN 110201100A CN 201910558038 A CN201910558038 A CN 201910558038A CN 110201100 A CN110201100 A CN 110201100A
Authority
CN
China
Prior art keywords
grams
drinking
integration
obesity
medicinal herbs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910558038.3A
Other languages
English (en)
Inventor
周国洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910558038.3A priority Critical patent/CN110201100A/zh
Publication of CN110201100A publication Critical patent/CN110201100A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482Cassia, e.g. golden shower tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536Prunella or Brunella (selfheal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明提供一种防治三高症、动脉硬化及肥胖症的药食同源组方,由以下按重量计的原料制成:枸杞18‑23克,葛根18‑23克,决明子18‑23克,荷叶8‑12克,玉米须18‑23克,夏枯草8‑12克,杜仲叶8‑12克,生山楂4‑8克。本发明的药食同源组方采用各种药食两用中草药,含有多种功能活性成分,不仅提高了功能因子的浓度,减少各种杂质的摄入,有助于减轻肝肾负担,具有增强人体抵抗力的作用;长期服用起到滋补肝肾、降压降糖、降脂减肥作用,防止动脉硬化及肥胖症的发生。

Description

一种防治三高症、动脉硬化及肥胖症的药食同源组方
技术领域
本发明属于中药保健品领域,具体涉及一种防治三高症、动脉硬化及肥胖症的药食同源组方。
背景技术
随着人们的生活水平的提高,高血压、高血脂、高血糖、动脉硬化、肥胖症的病人越来越多,中老年人的多发病,几乎占老年人群的90%,近年来患者的年龄出现年轻化的趋势,无时不威胁着人们的身体健康。多少人苦于长期患高血压、高血脂、高血糖、动脉硬化、肥胖症,时刻提心吊胆;多少人因患病成为社会的累赘;多少人因患病突然离开人世,留下的是惋惜和世人的遗憾。面对如此凶恶的“敌人”,西医头痛医痛,脚痛医痛的方法不能解决问题。有些治疗这些病的药品副作用很大,对患者的有些器官造成了损害,成为困惑患者的难题,因此副作用较低的防治高血压、高血脂、高血糖、动脉硬化及肥胖症的药食同源组方成为患者的迫切需要。
发明内容
针对现有技术中的不足之处,本发明提供一种防治三高症、动脉硬化及肥胖症的药食同源组方,其具有活滋补肝肾,降压降糖,降脂减肥的功效。
为了达到上述目的,本发明技术方案如下:
一种防治三高症、动脉硬化及肥胖症的药食同源组方,由以下按重量计的原料制成:枸杞18-23克,葛根18-23克,决明子18-23克,荷叶8-12克,玉米须18-23克,夏枯草8-12克,杜仲叶8-12克,生山楂4-8克。
进一步的,所述防治三高症、动脉硬化及肥胖症的药食同源组方,由以下按重量计的原料制成:枸杞20克,葛根20克,决明子20克,荷叶10克,玉米须20克,夏枯草10克,杜仲叶10克,生山楂6克。
本发明按上述比例混合,研磨成粉末状分装在密闭性好的包装袋内,用白开水冲沏饮用。
以下是所用原料的药性及所起的作用:
(1)枸杞:【性味】平、甘。【归经】肝经、肾经。【功效】滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明;
(2)葛根:【味性】平;辛、甘。【归经】胃经、脾经。【功效】升阳解肌,透疹止泻,除烦止温。治伤寒、温热头痛项强,烦热消渴,泄泻,痢疾,癍疹不透,高血压,心绞痛,耳聋;
(3)决明子:【味性】凉;甘、苦。【归经】肝经、肾经。【功效】清热明目,润肠通便。用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结;
(4)荷叶:【味性】平;苦。【归经】 胃经、脾经、肝经。【功效】清热解暑;升发清阳;散瘀止血。主暑湿烦渴;头痛眩晕;脾虚腹胀;大便泄泻;叶血下血;产后恶露不净;
(5)玉米须:【味性】平;甘。【归经】胃经、胆经、肝经、肾经。【功效】利尿消肿;清肝利胆。主水肿;小便淋沥;黄疸;胆囊炎;胆结石;高血压;糖尿病;乳汁不通;
(6)夏枯草:【性味】寒,苦、辛。【归经】归胆、肝经。【功效】清肝明目;散结解毒。主治目亦羞明;目珠疼痛;头痛眩晕;耳鸣;瘰疬;瘿瘤;乳痈;痄腮;痈疖肿毒;急、慢性肝炎;高血压病;
(7)杜仲叶:【性味】温,甘。【归经】肝经、肾经。【功效】补肝肾,强筋骨,安胎。用于肾虚腰痛,筋骨无力,妊娠漏血,胎动不安;高血压;
(8)生山楂:【性味】温,酸、甘。【归经】胃经、脾经、肝经。【功效】消食积;化滞瘀。主饮食积滞,脘腹胀痛,泄泻痢疾,血瘀痛经,闭经,产后腹痛;恶露不尽。
有益效果:本发明的药食同源组方采用各种药食两用中草药,含有多种功能活性成分,不仅提高了功能因子的浓度,减少各种杂质的摄入,有助于减轻肝肾负担,具有增强人体抵抗力的作用;长期服用起到滋补肝肾、降压降糖、降脂减肥作用,主治肝肾亏虚、高血压、高血脂、高血糖,而且没有毒副作用;能够较好地辅助治疗高血压、高血脂、高血糖,配合其他治疗手段能够有效地控制患者血压、血脂、血糖值在正常范围内,稳定病情,防止动脉硬化及肥胖症的发生。
具体实施方式
以下参照具体的实施例来说明本发明。本领域技术人员能够理解,这些实施例仅用于说明本发明,其不以任何方式限制本发明的范围。
实施例1
一种防治三高症、动脉硬化及肥胖症的药食同源组方,由以下按重量计的原料制成:枸杞20克,葛根20克,决明子20克,荷叶10克,玉米须20克,夏枯草10克,杜仲叶10克,生山楂6克。本发明按上述比例混合,研磨成粉末状装在密闭性好的包装袋内,并分装成10g/包,每日用白开水冲沏饮用一包。
实施例2
一种防治三高症、动脉硬化及肥胖症的药食同源组方,由以下按重量计的原料制成:枸杞23克,葛根23克,决明子23克,荷叶12克,玉米须23克,夏枯草8克,杜仲叶8克,生山楂4克。本发明按上述比例混合,研磨成粉末状装在密闭性好的包装袋内,并分装成10g/包,每日用白开水冲沏饮用一包。
实施例3
一种防治三高症、动脉硬化及肥胖症的药食同源组方,由以下按重量计的原料制成:枸杞18克,葛根18克,决明子18克,荷叶8-克,玉米须18克,夏枯草12克,杜仲叶12克,生山楂8克。本发明按上述比例混合,研磨成粉末状装在密闭性好的包装袋内,并分装成10g/包,每日用白开水冲沏饮用一包。
实施例4临床观察
经过对360例高血压、高血脂、高血糖患者的饮用治疗统计,饮用此药食同源组方配合其他治疗手段,血压、血脂、血糖值在正常范围的344例,各项指标稳定8例,无效8例,总有效率为97.7%,经过实验证明饮用此药食同源组方配合其他治疗手段能够很好地控制患者的血压、血脂、血糖值,稳定病情,并且无不良反应。
典型病例:
(1)马某某,男,45岁,患高血压2年,经过检查血压、血脂的指标较高,多饮、多食,血糖、血压值始终超出正常值,致使盗汗遗精、心肾功能异常身体非常虚弱,饮用本实施例1的药食同源组方配合其他治疗手段4周,血压、血脂、血糖值能够控制在正常值范围内,上述症状消失,并没有其他不良反应。
(2)吕某某,男,38岁,患高血脂、动脉硬化症1年。症见其人肥胖,反应大脑迟钝,四肢沉重懒行。饮用本实施例2的药食同源组方8周,症状明显减轻。继续服用12周,症状消失,一切检查均正常。
(3)孙某,男,59岁,医院诊断高血糖症,空腹血糖6.9mmol/L,餐后血糖10.3 mmol/L,尿糖检测为阳性。症状心跳快速,皮肤干燥,易口渴,食量大,体重减轻明显。曾服降糖西药,效果欠佳。饮用本实施例3的药食同源组方12周,空腹血糖6.2mmol/L,餐后血糖10.6mmol/L,尿糖检测转阴,继续跟踪回访,血糖下降,症状改善明显,身体自觉无任何不良反应。
(4)陆某,女,50岁,患高血压5年,平时血压高压160毫米高汞柱,低压110毫米高汞柱。服用降压片正常后,停药立即反弹上升。饮用本实施例1的药食同源组方4周,血压下降,继续服8周后,测量血压正常,停药一个月后测量血压仍无上升,病愈。

Claims (2)

1.一种防治三高症、动脉硬化及肥胖症的药食同源组方,其特征在于:由以下按重量计的原料制成:枸杞18-23克,葛根18-23克,决明子18-23克,荷叶8-12克,玉米须18-23克,夏枯草8-12克,杜仲叶8-12克,生山楂4-8克。
2.如权利要求1所述的防治三高症、动脉硬化及肥胖症的药食同源组方,其特征在于:由以下按重量计的原料制成:枸杞20克,葛根20克,决明子20克,荷叶10克,玉米须20克,夏枯草10克,杜仲叶10克,生山楂6克。
CN201910558038.3A 2019-06-26 2019-06-26 一种防治三高症、动脉硬化及肥胖症的药食同源组方 Pending CN110201100A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910558038.3A CN110201100A (zh) 2019-06-26 2019-06-26 一种防治三高症、动脉硬化及肥胖症的药食同源组方

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910558038.3A CN110201100A (zh) 2019-06-26 2019-06-26 一种防治三高症、动脉硬化及肥胖症的药食同源组方

Publications (1)

Publication Number Publication Date
CN110201100A true CN110201100A (zh) 2019-09-06

Family

ID=67794636

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910558038.3A Pending CN110201100A (zh) 2019-06-26 2019-06-26 一种防治三高症、动脉硬化及肥胖症的药食同源组方

Country Status (1)

Country Link
CN (1) CN110201100A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113499399A (zh) * 2021-07-30 2021-10-15 胡巧生 一种治疗糖尿病的口服制品及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105169034A (zh) * 2015-09-10 2015-12-23 曾丽 一种治疗高血压的中药组合物及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105169034A (zh) * 2015-09-10 2015-12-23 曾丽 一种治疗高血压的中药组合物及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113499399A (zh) * 2021-07-30 2021-10-15 胡巧生 一种治疗糖尿病的口服制品及其制备方法

Similar Documents

Publication Publication Date Title
CN104366636A (zh) 一种平卧菊三七复合制剂及制备方法及应用
CN103751714A (zh) 一种治疗气滞血瘀型高脂血症的中药制备方法
CN102987507B (zh) 一种适合糖尿病或便秘患者饮用的饮料及其制备方法
CN110201100A (zh) 一种防治三高症、动脉硬化及肥胖症的药食同源组方
CN104248717B (zh) 一种治疗高血压的足浴中药组合物及其制备方法
CN106490558A (zh) 一种保健蜂蜜及其制备方法
CN104367753B (zh) 一种治疗2型糖尿病的中药组合物
CN111068027B (zh) 调治阳虚质亚健康的中药组合物及其制备方法和应用
CN109010518A (zh) 降压茶及其制备方法和应用方法
CN104605111A (zh) 具有保健功效的鲜菠菜根代茶饮及制备方法
CN104096001A (zh) 一种治疗脾胃失司型干眼症的中药制剂及护理方法
CN104606571A (zh) 一种生津止渴鲜菠菜根代茶饮及制备方法
CN104770500A (zh) 一种具有降血压功效的养生茶叶及其加工方法
CN110074227A (zh) 一种凉茶饮配方及制备方法
CN103751496A (zh) 一种治疗寒湿困脾型高脂血症的中药制备方法
CN103520466B (zh) 治疗糖尿病性便秘的中药汤剂
CN109010516A (zh) 降压茶及其制备方法和应用方法
CN109007182A (zh) 一种盐地碱蓬降压保健茶及保健茶饮品和茶包
CN108126161A (zh) 一种治疗高血压的中草药及其制备方法和应用
CN107149670A (zh) 治疗糖尿病的药茶及其制备方法
CN102988902B (zh) 一种治疗脂肪肝的中药药丸
CN106173037A (zh) 一种固脾肾化湿浊治疗前列腺炎的药茶及制备加工方法
CN101129691A (zh) 当归疝气汤
CN103751600A (zh) 一种治疗风湿头痛型高脂血症的中药制备方法
CN105106600A (zh) 一种促进因车祸致脑部外伤手术后愈合的组合物及制法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190906